Request Trial

Marisa Woutersen

Key details

Marisa Woutersen is a senior reporter for Life Sciences Intellectual Property Review and World IP Review. She largely covers intellectual property developments across the global life sciences sector, including pharmaceuticals, biotechnology, medtech, AI, M&A and regulation.

Since joining Newton Media in 2023, Marisa has reported across a wide range of topics, from the rise of generative AI and its impact on the creative industries to the crossover between intellectual property and sport, including issues affecting athletes, as well as global pharmaceutical disputes, vaccine technology, access to medicines and life sciences M&A.

She has reported live from court and regularly travels to international conferences, where she interviews lawyers, business leaders and other key industry figures.

Marisa holds a Master’s in International Law and a BA in Politics and International Relations from the University of Sussex, and is currently completing her NCTJ Diploma in Journalism.

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine search
Total results: 456

Articles by Marisa Woutersen

Arnold & Porter loses another regulatory partner to growing rival
Careers
Arnold & Porter loses another regulatory partner to growing rival
A Brussels-based partner, specialising in pharmaceuticals and biologics, jumps ship as a competitor firm continues to build out its EU healthcare regulatory bench.   7 January 2026
Novo Nordisk secures China win ahead of key patent expiration
Asia
Novo Nordisk secures China win ahead of key patent expiration
Danish pharma giant notches an important victory in a huge market for semaglutide, but faces a patent cliff and mounting challenges across India, Canada and the US.   6 January 2026
Edwards v Meril: Inside the UPC’s landmark medtech showdown
Europe
Edwards v Meril: Inside the UPC’s landmark medtech showdown
As Edwards secures another win against its rival, LSIPR talks to Siddharth Kusumakar—partner at Powell Gilbert and counsel for the winning party.   6 January 2026
Careers
Bird & Bird targets Nordic life sciences growth with regulatory hire
The firm brings in a former Plesner director and Novo Nordisk in-house counsel with regulatory and compliance expertise.   5 January 2026
Europe
EU unveils sweeping pharma, biotech, and medical device reforms
Europe’s life sciences sector is getting a major overhaul. A spate of reforms promises faster approvals, less red tape, and more innovation, reports Marisa Woutersen.   23 December 2025
Europe
Abbott wins appeal to restore glucose monitoring patent
A UK appellate court has revived a key patent for the tech, finding flaws in the lower court’s handling of the case and obviousness analysis over prior art.   18 December 2025
Europe
Abbott appeals ‘baffling’ decision in glucose monitoring device feud
UK court hears claims that a delay and construction inconsistency led to the alleged wrongful invalidation of a patent at the heart of a global dispute.   16 December 2025
Europe
Diagnosis: What’s holding back UK life sciences?
The country aims to become the world’s third-largest life sciences economy by 2035, but stalled investments, regulatory hurdles, and talent shortages are raising questions about whether the target is achievable, finds Marisa Woutersen.   15 December 2025
Asia
Novo Nordisk ramps up semaglutide defence as generics lurk
The Danish pharma giant is expanding its patent defence in India as multiple generics prepare to challenge its blockbuster diabetes and weight-loss drug ahead of 2026 patent expiry.   9 December 2025
Europe
Marks & Clerk adds multi-jurisdictional disputes expert
The firm has added a disputes specialist with experience in pharma, biotech and manufacturing sectors across multiple jurisdictions.   8 December 2025

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.